Kyungsun Kyle Choi
is a foreign attorney in the firm's Health Practice Group and is a member of the Mergers & Acquisitions and Corporate Investigations and White Collar Practice Group. Ms Choi represents a broad range of companies in the pharmaceutical/medical device/food/cosmetic sectors, specialising in pharmaceutical regulation, pricing and reimbursement, compliance, bribery and competition law issues relating to promotional and marketing practices in the industry, anti-counterfeiting strategies, M&A, and restructuring of business operations. Her representative work in recent years includes assisting a major multinational pharmaceutical company in a product liabilities litigation under the country's relatively new Product Liability Law, advising the Korean subsidiary of a multinational pharmaceutical company in a buy-out of a local partner in a longstanding joint-venture company, and assisting multiple multinational pharmaceutical companies to put in place or strengthen codes of conduct and compliance programmes. Ms Choi has also defended clients in pharmaceutical cases in a wide range of internal and government investigations for corporate fraud, corruption, fair trade law and anti-bribery offences.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.